WAM
LABU icon

Wolverine Asset Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Wolverine Asset Management’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10
Closed -$18K – 1573
2018
Q2 		$18K Sell
10
-300
-97% -$528K ﹤0.01% 1312
2018
Q1 		$492K Sell
310
-510
-62% -$950K 0.01% 974
2017
Q4 		$1.28M Buy
820
+310
+61% +$475K 0.01% 667
2017
Q3 		$871K Buy
+510
New +$708K 0.01% 701

Other funds holding LABU

HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wolverine Asset Management's LABU Position: Q3 2018 in Review

Wolverine Asset Management sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2018, closing a stake of 436 shares — an estimated $827K sold.

Wolverine Asset Management first reported a position in LABU in Q4 2017 and held it in 3 quarters. The position peaked at $5.73M in Q1 2018. 18 funds tracked by Wall St. Rank hold LABU as of Q3 2018.

  • Wolverine Asset Management reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2018 after selling out during the quarter.
  • Wolverine Asset Management sold 436 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2018, an estimated $827K.
  • Wolverine Asset Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2017 and held it in 3 quarters.
  • Wolverine Asset Management's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $5.73M in Q1 2018.
  • 18 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2018.

Based on Wolverine Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.